Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18320)	1/29/1999 1:28:00 AM
From: Andreas Samson	Read Replies (2) \| Respond to of 23519

Thank you, Vlad, for the due diligence you have done, on behalf of all shareholders, including myself. Like I said, you're a stand-up guy. As to Sweden....yes, I am encouraged that they have held 34% market share. But I have to wonder: 34% of what? How big a market is Sweden? It's not so big that it makes up for the projected decrease in int'l shipments/revenues for the next two quarters. Not even close. If we could see these numbers repeated in other countries, in successive quarters, then we're talking a new ball game. Time will tell. On the domestic front...SG&A is down to the bone: $1.9M from $13.4M last year. R and D is down by 45% y/y. There's not much fat left to cut. Again, even with milestones factored in, we're looking at decreased sales going forward, and negative earnings, in all likelihood, until Q3. And that, surely even you will agree, is a very fair interpretation of what was said in the CC. It requires a sublime faith in MUSE to put a happy face on those facts...you have it. I don't.